Clinical trial Recruiting at 2 sites Interventional Ages 18 and up Women only

Double-layer vaginal vault closure with self-locking versus traditional sutures after laparoscopic hysterectomy for gynecologic cancer

Official title: Comparison Between Double-Layer Self-Locking and Traditional Sutures in Post-Hysterectomy Laparoscopic Colporrhaphy: A Multicenter Pragmatic Randomized Controlled Trial

Run by Azienda Ospedaliero-Universitaria di Parma · NCT07313839 · Data updated 2026-11-12

This trial tests whether double-layer self-locking (barbed) sutures reduce vaginal cuff complications compared with traditional Polyglactin 910 sutures in adults having laparoscopic or robotic hysterectomy for gynecologic cancer.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment310 (estimated)
SponsorAzienda Ospedaliero-Universitaria di Parma
Academic / other
Locations5 sites (Parma, Italy and 4 other locations)
StatusRecruiting
StartedOctober 7, 2025
Main results expectedJanuary 2027
Study endsJanuary 2027
Registry record updatedJune 17, 2026
Trial IDNCT07313839 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older undergoing laparoscopic or robot-assisted hysterectomy for gynecologic malignancy who can provide written informed consent are the intended participants.

Probably not a fit

Patients undergoing open (laparotomic) or vaginal hysterectomy or those with contraindications to laparoscopic vaginal vault closure are unlikely to be eligible or to benefit from the comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multicenter, randomized controlled trial comparing double-layer self-locking (barbed) sutures to double-layer Polyglactin 910 sutures for laparoscopic or robot-assisted vaginal vault closure after hysterectomy for malignant gynecologic disease. Eligible patients are randomized 1:1 at participating Italian centers and undergo the assigned closure technique as part of their planned minimally invasive surgery. Outcomes including vaginal cuff dehiscence, infection, bleeding, and postoperative pain are recorded for up to three months after surgery. The trial is pragmatic in design and focuses on the effectiveness and safety of the two suture approaches specifically in the oncologic setting.

Why it matters

Potential benefit: If successful, this approach could reduce vaginal cuff complications, postoperative pain, and the need for additional procedures after minimally invasive hysterectomy.

How similar studies have gone: Previous small trials and observational studies, largely in benign hysterectomy, suggest barbed sutures can shorten suturing time with similar short-term complication rates, but robust randomized evidence for double-layer closure in cancer surgery is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients undergoing laparoscopic or robotically assisted hysterectomy for gynecologic malignant disease
* Age ≥ 18 years
* Ability to provide written informed consent

Exclusion Criteria:

* Laparotomic or vaginal hysterectomy
* Contraindication to laparoscopic vaginal vault closure

Where it's running

  • Department of Medicine and Surgery, University Hospital of Parma
    Parma, Italy, Italy
    Recruiting
  • Department of Obstetrics and Gynecology, Ospedale Santa Croce e Carle, Cuneo, Italy.
    Cuneo, Italy
    Recruiting
  • Division of Oncologic Gynecology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
    Bologna, Italy
    Not yet recruiting
  • Department of Gynecologic Oncology. Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
    Milan, Italy
    Not yet recruiting
  • Clinic of Obstetrics and Gynecology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
    Udine, Italy
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.